Skip to main content
. 2021 Dec 24;11:183. doi: 10.1186/s13613-021-00971-w

Table 1.

Baseline characteristics of patients according to their status, namely, bloodstream infection or not

Number with missing data Patients with BSI
n = 780
Patients without BSI
n = 3230
p-value
Age, years 0 62 [53–69] 63 [54–71] 0.019
Frailty scale 395 2 [2, 3] 2 [2, 3] 0.80
Male gender 23 607 (78) 2346 (73) 0.004
Body mass index, kg/m2 292 29 [26–33] 28 [25–32] 0.006
Living place 69 3175 0.006
 Admission from a long-term care facility 25 (3) 48 (2)
 Admission from nursing home 3 (0) 29 (1)
 Admission from home 738 (96) 3098 (3)
Severity on admission
 SAPS II 323 40 [30–54] 36 [27–48] < 0.001
 SOFA score 562 7 [4–9] 4 [3–8] < 0.001
ARDS severity on admission 820 < 0.001
 No ARDS 54 (7) 365 (13)
 Mild ARDS 146 (19) 630 (22)
 Moderate ARDS 343 (46) 1292 (44)
 Severe ARDS 190 (26) 630 (22)
Comorbidities
 No comorbidities 27 126 (16) 588 (18) 0.18
 Alcohol consumption 827 26 (4) 134 (5) 0.28
 Tabaco consumption 839 32 (5) 135 (5) 0.89
 Chronic respiratory disease 677 183 (28) 671 (26) 0.23
 Chronic heart failure 6 20 (3) 131 (4) 0.064
 Hypertension 4 379 (49) 1523 (47) 0.47
 Coronary artery disease 1 82 (11) 348 (11) 0.89
 Diabetes mellitus 2 231 (30) 866 (27) 0.12
 Hematological malignancy 0 22 (3) 87 (3) 0.94
 Immunodepression 773 62 (10) 221 (9) 0.45
 Solid malignancy 0 9 (1) 50(2) 0.51
 Transplantation 0 21 (3) 62 (2) 0.22
 Chronic renal failure 773 77 (24) 301 (23) 0.90
 Cirrhosis 668 3 (0) 25 (1) 0.32
 Neuromuscular disease 774 28 (4) 69 (3) 0.037
Home treatment
 Long-term corticosteroids treatment 1 36 (5) 129 (4) 0.49
 Immunomodulatory drugs 1 42 (5) 125 (4) 0.072
 Treatment with NSAID 536 58 (9) 171 (6) 0.022
Time from hospital admission to ICU, days 153 1 [0–3] 1 [0–3] 0.49
Period of admission 326 0.94
 Before 15th of March 2020 46 (6) 187 (6)
 From 15th March to 31th of March 2020 439 (61) 1766 (60)
 From 1st April to 15 April 2020 193 (27) 841 (28)
 After 15th of April 2020 40 (5) 172 (5)
 Nurse/patient ratio 713 2 [2, 3] 2 [2, 3] 0.61
Admission during night-hours* 0 393 (50) 1570 (48) 0.39
Fever before admission 146 634 (85) 2567 (82) 0.16
Abdominal symptoms before admission 140 211 (27) 901 (28) 0.67
Co-infection at admission 123 76 (10) 247 (7.9) 0.070
 Bacterial co-infection 66 (8) 217 (7) 0.10
 Viral co-infection 4 (0) 21 (0) 0.86
Hospital/ICU treatment
Antiviral treatment before admission 13 384 (49) 1451 (45) 0.033
Immunomodulatory drugs 12 (2) 47 (1) 0.99
Tocilizumab use 5 (1) 26 (1) 0.81
Intubation before admission 26 243 (31) 629 (20) < 0.001
Management during period at risk for BSI
 Number of day at risk for BSI, days 143 7 [3–11] 12 [15–22] < 0.001
 ICU-acquired pneumonia during period at risk for BSI 165 238 (31) 1096 (34) 0.075
 Corticosteroids during period at risk for BSI 21 171 (22) 969 (30) < 0.001
 Renal replacement therapy during period at risk for BSI 14 18 (2) 569 (18) < 0.001
 ECMO support during period at risk for BSI 14 68 (9) 195 (6) 0.009
 Antibiotics use during period at risk for BSI 7 618 (79) 2871 (89) < 0.001

Categorical variables are expressed as n (%) and continuous variables as median [interquartile range]

BSI: Bloodstream infection; SOFA: sequential-organ failure assessment; ARDS: Acute respiratory distress syndrome; NSAID: Non-steroidal anti-inflammatory drugs; ICU: Intensive care unit; RRT: renal replacement therapy; ECMO: Extra corporeal membrane oxygenation

*Admission during night hours was arbitrarily defined as admission in between 8:00 PM to 8:00 AM